Clinical trials
Phase 2/3 Schizophrenia trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2008 | 1 |
| 2010 | 2 |
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Terminated | 6 |
| Recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Manhattan Psychiatric Center | 2 |
| Mclean Hospital | 2 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 |
| SyneuRx International (Taiwan) Corp | 2 |
| University of Maryland, Baltimore | 2 |
| Yale University | 2 |
| Abraham Reichenberg | 1 |
| Chengappa, K.N. Roy, MD | 1 |
| Denovo Biopharma LLC | 1 |
| Nathan Kline Institute for Psychiatric Research | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Schizophrenia | 21 |
| Psychotic Disorders | 8 |
| Cognitive Dysfunction | 2 |
| Affective Disorders, Psychotic | 1 |
| Bipolar Disorder | 1 |
| Cognition Disorders | 1 |
| Diabetes Mellitus | 1 |
| Inflammation | 1 |
| Marijuana Abuse | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.